Treatment-related diabetes and cardiovascular disease in prostate cancer survivors.
Smith
M R
MR
Genitourinary Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003920:Diabetes Mellitus / Q000139:chemically induced*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D017741:Survivors
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone